Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE Study
Objectives Although uric acid lowering therapies, including xanthine oxidase (XO) inhibition, may reduce the absolute level of blood pressure (BP), the effect of XO inhibition on BP variability is largely unknown. The aim of the present analysis was to evaluate the impact of febuxostat, an XO inhibi...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-09-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/8/2/e002505.full |